In a new study, UNC School of Medicine’s Brian Conlon, PhD, Duke’s Josh Parsons, MD, PhD, and colleagues provide the best evidence to date for the significance of bacterial persister cells in the failure of antibiotics in the clinic.
In a new study, UNC School of Medicine’s Brian Conlon, PhD, Duke’s Josh Parsons, MD, PhD, and colleagues provide the best evidence to date for the significance of bacterial persister cells in the failure of antibiotics in the clinic.